National and Kapodistrian University of Athens
Ο ρόλος των micro-RNAs στην παρακολούθηση ασθενών με τυχαιώματα επινεφριδίων
Abstract
dc:descriptionAdrenal tumours (ATs) encompass a wide differential diagnosis, necessitating a multi-step process for accurate identification. Liquid biopsy emerges as a promising non-invasive technique for distinguishing malignant from benign as well as secreting from non-secreting cases. Recent studies have highlighted the potential of microRNAs as circulating biomarkers; however, their clinical utility remains underexplored. This study aims to validate the diagnostic performance of selected circulating microRNAs, (miR-483-5p, miR-210, miR-335, miR-22-3p), identified through microRNA profiling studies, as markers of malignancy or cortisol hypersecretion in a cohort of patients with ATs. We collected serum samples from 90 participants, including 75 patients with ATs and 15 controls. The ATs comprised 50 cases of adrenocortical adenomas (ACA) and 25 cases of adrenocortical carcinomas(ACC). In the ACC subgroup, 16 samples were obtained preoperatively or upon detection of recurrence(active ACC group), while the remaining from disease-free patients with long-term follow-up (disease-free ACC group). Among the 56 patients with ATs evaluated preoperatively (50 with ACAs and 6 with ACC), 26 had non-functioning tumours, 22 exhibited mild autonomous cortisol secretion (MACS), and8 had Cushing syndrome (CS). Quantitative real-time polymerase chain reaction was employed to analyze microRNA expression. Circulating levels of miR-483-5p and miR-210 were significantly elevated in patients with active ACC compared to both ACAs (p<0.001 and p=0.004, respectively) and controls (p=0.002 and 0.003,respectively). Notably, miR-483-5p serum levels were higher in the group of active compared to disease-free ACC patients (p = 0.01). MiR-483-5p demonstrated the best diagnostic accuracy for distinguishing active ACC cases from ACAs (AUC=0.869, 95%CI: 0.761–0.978, p<0.001), achieving a sensitivity of 81.3% and a specificity of 88%, and from disease-free ACC patients (AUC=0.854,95%CI: 0.672–1, 230 p=0.004), reaching sensitivity of 81.3% and specificity of 89%. In contrast, miR-335 levels were not sufficient to differentiate the groups. A sub-analysis within ACC cases revealed a trend toward higher marker levels in preoperative samples compared to recurrent cases, although the observed differences were not statistically significant. MiR-22-3p serum levels successfully differentiated patients with CS from those with non-functioning ATs (area under the curve=AUC=0.800, 95% CI: 0.653–0.953, p=0.01) and controls (AUC= 0.800, 95% CI: 0.610–0.990,p=0.02). Additionally, circulating miR-22-3p levels exhibited a significant correlation with traditional diagnostic tests for hypercortisolism. Our study highlights the potential of circulating miR-483-5p and miR-210 as promising non-invasive biomarkers for distinguishing active ACC cases from ACA. The absence of miR-483-5p expression in disease-free ACC patients, in which tumor burden is low or absent, suggests that this biomarker may be useful not only for diagnostic purposes but also for disease monitoring. Additionally, we validated the effectiveness of miR-22-3p in detecting overt hypercortisolism. Future research should focus on analyzing serial serum samples from ATs patients to better understand miRNA dynamics throughout disease progression and in response to treatment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mytareli, Chrysoula
- Μυταρέλη, Χρυσούλα
Subjects
dc:subject × 15- Επινεφριδιακοί όγκοι
- Βιοδείκτες
- Micro-RNAs
- Υγρή βιοψία
- Φλοιοεπινεφριδιακό καρκίνωμα
- Adrenal tumours
- Biomarkers
- Liquid biopsy
- Adrenocotical carcinoma
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ενδοκρινικό και Αυτόνομο σύστημα
- Basic Medicine
- Medical and Health Sciences
- Endocrine and Autonomic Systems
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58778